Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
European Union
Pharma
CHMP again backs Leqembi amid flurry of approval recommendations
Following a flurry of activity at Europe's CHMP this week, drugmakers are celebrating regulatory endorsements for big-name meds.
Fraiser Kansteiner
Feb 28, 2025 10:30am
EU to probe possible link between Ozempic, eye disorder: report
Dec 17, 2024 3:25pm
EU authorities revoke marketing nod for Advanz Pharma's Ocaliva
Dec 2, 2024 2:54pm
EU regulators endorse meds from BMS, J&J, Eisai and more
Nov 15, 2024 10:05am
ARS inks ex-US licensing pact for Neffy worth up to $465M
Nov 11, 2024 9:44am
Teva hit with €463M fine over Copaxone misconduct claims in EU
Oct 31, 2024 10:45am
